ArticleCancer research2015
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models.
Catherine A Eberlein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
174 papers cite itlatest 60 shown
this paperpooled ittrialcites it